Contradictory results were obtained by the team of Aroner et al. [50], who found no significant differences between serum MMP-7 levels and the molecular subtypes of BC, which is in agreement with our results, with no significant differences in levels being observed between the Luminal A and Luminal B HER2-negative BC groups. This evidence concerns the gene ERBB2 and breast cancer.